Status:
COMPLETED
Theta Burst Stimulation for Schizophrenia
Lead Sponsor:
Duke University
Conditions:
Schizophrenia
Schizoaffective Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Purpose and objective Schizophrenia is a chronic debilitating illness with cognitive deficits that cause serious impairment in psychosocial recovery and with few treatments to remediate these deficits...
Detailed Description
Purpose of the study Aim1: Evaluate the effect of theta burst stimulation (TBS) on working memory (WM) in patients with schizophrenia. Hypothesis 1 - There will be significant improvement in WM compar...
Eligibility Criteria
Inclusion
- Patients aged 18-65 years of age with schizophrenia or schizoaffective disorder
- No other mental health diagnoses
- Right handed males and females
- May have mild positive symptoms (score of \</= 21)
- May have negative symptoms
- Ability to provide informed consent
- No restriction on concomitant medications given
Exclusion
- Intellectual disability
- Any organic brain illness Presence of dementia symptoms or traumatic brain injury Primary diagnosis of substance use Seizure disorder Actively symptomatic with PANSS positive symptom sub-scale \>21. Concurrently receiving electroconvulsive therapy (ECT)
Key Trial Info
Start Date :
October 24 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2018
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT03288779
Start Date
October 24 2017
End Date
June 30 2018
Last Update
November 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University Medical Center
Durham, North Carolina, United States, 27710